Biohaven and Pfizer announce positive topline results of rimegepant to treat migrane
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
Sputnik Light as a booster significantly increases virus-neutralizing activity against Omicron based on sera 2-3 months after revaccination and is a universal booster to other vaccines inducing stronger antibody and T-cell response
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour
Subscribe To Our Newsletter & Stay Updated